Belpointe Asset Management »

Silverback Therapeutics shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $190k 19k 10.05
2025-06-30 $302k 17k 17.45